LumiraDx Limited (LMDXF)
- Previous Close
0.0250 - Open
0.0233 - Bid --
- Ask --
- Day's Range
0.0175 - 0.0285 - 52 Week Range
0.0070 - 0.5600 - Volume
1,870,773 - Avg. Volume
877,221 - Market Cap (intraday)
246.507M - Beta (5Y Monthly) 0.27
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 14, 2024 - May 20, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.65
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company is headquartered in London, the United Kingdom.
www.lumiradx.com1,210
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: LMDXF
Performance Overview: LMDXF
Trailing total returns as of 5/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LMDXF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LMDXF
Valuation Measures
Market Cap
7.63M
Enterprise Value
385.04M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.06
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-267.19%
Return on Assets (ttm)
-28.04%
Return on Equity (ttm)
--
Revenue (ttm)
126.52M
Net Income Avi to Common (ttm)
-338.04M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
25.34M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-54.01M
Research Analysis: LMDXF
Company Insights: LMDXF
LMDXF does not have Company Insights